Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis
about
Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitisThe Role of Oxidative Stress and Antioxidants in Liver DiseasesReview of nonalcoholic fatty liver disease in women with polycystic ovary syndromeOxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosisHerbal adaptogens combined with protein fractions from bovine colostrum and hen egg yolk reduce liver TNF-α expression and protein carbonylation in Western diet feeding in ratsDoes vitamin E improve the outcomes of pediatric nonalcoholic fatty liver disease? A systematic review and meta-analysisManagement of nonalcoholic fatty liver disease: an evidence-based clinical practice review.Grape seed extract to improve liver function in patients with nonalcoholic fatty liver change.Effects of α-tocopherol and β-carotene supplementation on liver cancer incidence and chronic liver disease mortality in the ATBC studyAntioxidants as therapeutic agents for liver disease.Association between Dietary Vitamin C Intake and Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study among Middle-Aged and Older Adults.A Complex Multiherbal Regimen Based on Ayurveda Medicine for the Management of Hepatic Cirrhosis Complicated by Ascites: Nonrandomized, Uncontrolled, Single Group, Open-Label Observational Clinical Study.Protective effects of saffron extract and crocin supplementation on fatty liver tissue of high-fat diet-induced obese ratsFocus on therapeutic strategies of nonalcoholic Fatty liver diseaseHepatic function and the cardiometabolic syndrome.Nutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD).Peroxisome Proliferator-Activated Receptor-γGene Expression and Its Association with Oxidative Stress in Patients with Metabolic Syndrome.Nitric oxide and redox regulation in the liver: part II. Redox biology in pathologic hepatocytes and implications for intervention.Role of the diet as a link between oxidative stress and liver diseasesThe role of nutraceuticals for the treatment of non-alcoholic fatty liver disease.Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD): an attempted network meta-analysis.N-acetylcysteine improves liver function in patients with non-alcoholic Fatty liver disease.Prebiotic and Synbiotic Modifications of Beta Oxidation and Lipogenic Gene Expression after Experimental Hypercholesterolemia in Rat Liver.Hepatic VLDL assembly is disturbed in a rat model of nonalcoholic fatty liver disease: is there a role for dietary coenzyme Q?New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis
P2860
Q24198072-C51FF9EF-38BB-402A-83D7-78295D81E12BQ26779146-C2F2B525-99D8-4703-A3AA-29C1D1A8FDB9Q26828765-E4902C98-156A-4E27-828C-AAEC2F33E20BQ28084150-8489667E-30D4-4479-B392-748E248B2B1FQ33597943-E6B69398-022A-4054-A139-E30D1E154D14Q33796012-B25BB4E8-D71D-43DA-A18C-4667E94E5CC9Q34168532-D09E7556-44FC-4DC7-9398-4543CFC598A3Q34411957-5A3AE783-7D13-479E-AD06-CB39C2C40390Q34687005-13A28156-7F82-4F9B-ACB2-ED31F9BD593FQ35585469-01982599-F64B-4243-8F44-2C30B1DAA7FDQ35908245-D45702E9-BD3E-4158-951D-14D720ABC762Q35962702-726EE0AA-4F9E-41CA-A681-F9D9FC7C30B2Q36172121-6CF26965-ACDE-4D9E-87FB-72F17C7A3707Q36413703-7F17A54A-DB1E-439B-B2FD-105E5F78DBF9Q37232122-61A11226-D84F-4C72-AF92-4A70049F0BBAQ37286751-18C775A2-2CDE-4D5C-A988-CB13AAD8E26AQ37293331-FCDB3D8A-D309-451A-AADB-443C790DC1E7Q37733072-C1D2F01B-A188-496F-A2D6-5F26E57C41E7Q38320278-7AB6B516-DB9E-43E2-8132-1E8B4C02087FQ38725130-55B07B0C-70D3-4AC9-A8A9-4833D4CD701DQ38867031-F81BE733-0669-4EB3-A145-BE6F73F47420Q40789557-5E571430-5D62-40E1-BAFD-F070FF7174E3Q45399180-0AD3A5B3-FC12-4A4A-BBE1-CDC90DCAD707Q45927414-6CC53808-742A-4020-BC40-0AFADCC56691Q57114860-0FC8E1B1-6CEC-4896-B859-108F5FEFFB2A
P2860
Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis
@ast
Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis
@en
Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis
@en-gb
Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis
@nl
type
label
Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis
@ast
Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis
@en
Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis
@en-gb
Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis
@nl
prefLabel
Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis
@ast
Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis
@en
Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis
@en-gb
Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis
@nl
P2093
P2860
P3181
P1476
Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis
@en
P2093
P2860
P304
P3181
P356
10.1002/14651858.CD004996.PUB3
P577
2007-01-24T00:00:00Z